Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function

Journal of Paediatrics and Child Health

Volumn 36, Issue 2, 2000, Pages 101-107

  Doyle, L W ^a,b   Davis, P G ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cerebral palsy; Disability; Infant; Meta analysis; Outcome

Indexed keywords

CORTICOSTEROID;

CEREBRAL PALSY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; META ANALYSIS; MORTALITY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PERINATAL DRUG EXPOSURE; PREMATURITY; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR NEUROPATHY; SURVIVAL;

ADRENAL CORTEX HORMONES; CEREBRAL PALSY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MOTOR ACTIVITY; POSTNATAL CARE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS;

EID: 0034108705     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2000.00481.x     Document Type: Review

References (43)

1. 1 Bhuta T, Ohlsson A, Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed. 1998; 79: F26-F33.
2. 2 Halliday HL, Ehrenkranz RA. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, 1999.
3. 3 Halliday HL, Ehrenkranz RA. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, 1999.
4. 4 Halliday HL, Ehrenkranz RA. Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). In: The Cochrane Library, Issue 1. Update Software, Oxford, 1999.
5. 5 Soll RF. for the Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatr. Res. 1999; 45: 226A.
6. 6 Watterberg KL, Gerdes JS, Gifford KL, Lin H-M. Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104: 1258-63.
7. 7 Garland JS, Alex CP, Pauly TH et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial. Pediatrics 1999; 104: 91-9.
8. 8 Kothadia JM, O'Shea TM, Roberts D, Auringer ST, Weaver RG, Dillard RG. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Pediatrics 1999; 104: 22-7.
9. 9 Jones R, Wincott E, Elbourne D, Grant D. Controlled trial of dexamethasone in neonatal chronic lung disease: A 3-year follow-up. Pediatrics 1995; 96: 897-906.
10. 10 Yeh TF, Lin YJ, Huang CC et al. Early dexamethasone therapy in preterm infants: A follow-up study. Pediatrics. 101;URL http://wwwpediatricsorg/cgi/content/full/101/5/e7, 1998.
11. 11 Cochrane Neonatal Group. Search strategy for specialized register. In: Sinclair JC, Bracken MB, Soll RF, Horbar JD, eds. The Cochrane Library, Issue I. Update Software, Oxford, 1999.
12. 12 Cochrane Review Manager Software (RevMan), Version 301, October, 1997.
13. 13 Baden M, Bauer CR, Colle E, Klein G, Taeusch HW Jr, Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 1972; 50; 526-34.
14. 14 Avery GB, Fletcher AB, Kaplan, M, Brudno DS. Controlled trial of dexamethasone in respirator-dependent infants with broncho-pulmonary dysplasia. Pediatrics 1985; 75: 106-11.
15. 15 Ariagno RL, Sweeney TJ, Baldwin RB, Inguillo D, Martin D. Dexamethasone effects on lung function and risks in three week old ventilator dependent preterm infants. Am. Rev. Resp. Dis. 1987; 135: A125.
16. 16 Cummings JJ, D'Eugenio DB, Gross SJ. A Controlled trial of dexamethasone in preterm infants at high risk for broncho-pulmonary dysplasia. N. Engl. J. Med. 1989; 320: 1505-10.
17. 17 Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ. Dexamethasone therapy for chronic lung disease in ventilator-and oxygen-dependent infants: A controlled trial. J. Pediatr. 1989; 115; 979-83.
18. 18 Kazzi NJ, Brans YW, Poland RL. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are ventilator dependent on artificial ventilation. Pediatrics 1990; 86: 722-7.
19. 19 Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J. Pediatr. 1990; 117: 273-82.
20. 20 Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 1991; 88: 421-7.
21. 21 Ohlsson A, Calvert SA, Hosking, M, Shennan, AT Randomized controlled trial of dexamethasone treatment in very low birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr. 1992; 81: 751-6.
22. 22 Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO, Dexamethasone treatment in preterm infants at risk for broncho-pulmonary dysplasia. Arch. Dis. Child. 1993; 68: 566-9.
23. 23 Sanders RJ, Cox C, Phelps DL, Sinkin RA, Two doses of intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr. Res. 1994; 36: 122-8.
24. 24 Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: A randomized controlled trial. Pediatrics 1995; 95: 584-90.
25. 25 Brozanski BS, Jones JG, Gilmour CH et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J. Pediatr. 1995; 126: 769-76.
26. 26 Suske G, Oestreich K, Varnholt V, Lasch P, Kachel W. Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants. Acta Paediatr. 1996; 85: 713-8.
27. 27 Shinwell ES, Karplus M, Zmora E et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch. Dis. Child. 1996; 74: F33-F37.
28. 28 Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996; 98: 204-10.
29. 29 Subhedar NV, Ryan SW, Shaw NJ. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch. Dis. Child. 1997; 77: F185-F190.
30. 30 Yeh TF, Lin YJ, Hsieh WS et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: A multicenter clinical trial. Pediatrics. 100: URL http://wwwpaeditricsorg/cgi/content/ full/100/4/e3, 1997.
31. 31 Sinkin RA, Dweck HS, Horgan MJ, Gallaher KJ, Cox C, Phelps DL. Early intravenous dexamethasone (dex) for the prevention of BPD in surfactant treated babies with RDS. Pediatr. Res. 1998; 43: 195A.
32. 32 Tapia JL, Ramirez R, Cifuentes J et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J. Pediatr. 1998; 132: 48-52.
33. 33 Vincer MJ, Allen AC. Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW) < 1500 grams)) who (sic) ventilator dependent at 4 weeks of age. Pediatr. Res. 1998; 43: 201A.
34. 34 Kovacs L, Davis GM, Faucher D, Papageorgiou A. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr. 1998; 87: 792-8.
35. 35 Papile L-A, Tyson JE, Stoll BJ et al. A multicenter trail of two dexamethasone regimens in ventilator-dependent premature infants. N. Engl. J. Med. 1998; 338: 1112-8.
36. 36 O'Shea TM, Kothadia JM, Klinepeter KL et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age. Pediatrics 1999; 104: 15-21.
37. 37 The Victorian Infant Collaborative Study Group. Postnatal corticosteroids and sensorineural outcome at 5 years of age. J. Paediatr. Child Health 2000; 36: (in press).
38. 38 Taeusch WH Jr. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity. J. Pediatr. 1975; 87: 617-23.
39. 39 Silverman WA. Retrolental fibroplasia: A modern parable. Monographs in Neonatology. In: TK Oliver Jr, ed. Monographs in Neonatology. Grune and Stratton, New York, 1980;
40. 40 Ibid, p, 47.
41. 41 Ibid, p 38.
42. 42 Ibid, p, 41.
43. 43 Ibid, p, 53-58.